The Jerusalem PostPentagon ignored warnings before Iranian drone strike killed six US soldiers, whistleblower allegesInquirer EntertainmentBianca Gonzalez shares how PBB prepares evictees for outside lifeInquirerAnnual 3-month sardine fishing ban starts in Zamboanga PeninsulaDaily MaverickANC cannot renew itself by looking inwards while voters turn awayZDF heuteEntdecken Sie das ZDF-NachrichtenstudioVilaWebLa CUP aposta pel conflicte amb l’estat espanyol com a via d’avenç socialRTL BoulevardACM: Investeerder HAL mag bouwbedrijf VolkerWessels overnemenSRF NewsGlobale Panne – Alter Programmfehler löste Microsoft-Ausfall ausEgypt IndependentTV host Amr Adib comments on Egyptian state selling lands to pay off debtABC NewsWATCH: New video of tanker collision and riverboat sinkingTechCrunchGoogle Maps can now build trip itineraries with real-time details about each stopVanguardASUP declares indefinite strike at Rivers polytechnic
The Daily Newsstand · Free, Always
Monday, November 16, 2026

Nasus Pharma appoints Nir Sassi as CFO

Translate

Nasus Pharma (NSRX) announced Monday the appointment of Nir Sassi as chief financial officer, effective November 11, 2026.

The company noted that Sassi most recently served as CFO of Indaptus Therapeutics. Previously, he served as CFO of Intec Pharma and began his professional

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.